Fady Ibraham Malik - Sep 17, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Stock symbol
CYTK
Transactions as of
Sep 17, 2024
Transactions value $
-$372,213
Form type
4
Date filed
9/17/2024, 04:15 PM
Previous filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $42.2K +5.3K +4.31% $7.96 128K Sep 17, 2024 Direct
transaction CYTK Common Stock Sale -$301K -5.3K -4.13% $56.77 123K Sep 17, 2024 Direct
transaction CYTK Common Stock Sale -$114K -2K -1.63% $56.76 121K Sep 17, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -5.3K -14.29% $0.00 31.8K Sep 17, 2024 Common Stock 5.3K $7.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).